About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Provides Update on TPM Propofol Development Program
November 9, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Mylan Arbitration Hearing Concluded
Next Post
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products
Related Posts
Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial
December 8, 2014
2016 July 29 CEO Quarterly Update
July 29, 2016
Ethics Approval received for Phase III Clinical Trial
December 22, 2022
December 22, 2022